Loading…
TIL
Instil Bio, Inc.
NASDAQ· Healthcare· Biotechnology· CUSIP 45783C200
$7.58-3.56%Price as of Aug 29, 18:32 UTC · updated once a day, after the close
Key metrics
- Market cap
- $51.41M
- P/E
- —
- Forward P/E
- —
- P/B
- 0.5x
- Dividend yield
- —
- Payout
- —
- EPS
- -$4.40
- ROE
- -25.33%
- Profit margin
- 0.00%
- Revenue growth
- —
- Beta
- 1.91
- 52-week high
- $33.83
- 52-week low
- $5.67
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -98.2% over 5Y.
today you would have $20.06▼ -98.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 5 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Year-end price | $11.00 | $19.09 | $7.62 | $12.60 | $342.20 | |
| P/S | — | 8.3x | 29.2x | — | — | — |
| P/B | 0.7x | 0.7x | 0.7x | 0.2x | 0.2x | 4.0x |
| EPS | -$10.70 | -$11.39 | -$24.00 | -$34.46 | -$29.60 |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| PRPOPrecipio, Inc. | $28.85 | — | 3.5x | — | -8.98% | $51.65M |
| TCRXTScan Therapeutics, Inc. | $0.75 | — | 0.5x | — | -95.81% | $51.07M |
| ELOXEloxx Pharmaceuticals, Inc. | $15.07 | 4.7x | 1.3x | — | — | $51.79M |
| MDAISpectral AI, Inc. | $1.57 |
About the company
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
- 17
- Dallas, United States
Company description provided by Yahoo Finance.